Issue 1/2023

PARP in colorectal cancer: Molecular mechanisms, immunity, clinical trials, and drug combinations (1 — 14)

Fa-Hong Wu, Hang-Zhi Wei, Hong-Yang Deng, Guo-Hui Xiao,  You-Cheng Zhang

DOI: 10.4149/neo_2022_220724N745

Prevention and therapy of chemotherapy-induced peripheral neuropathy: a review of recent findings (15 — 35)

 Zuzana Michalová, Eva Székiová, Juraj Blaško, Ivo Vanický

DOI: 10.4149/neo_2022_221007N992

Identification and validation of circulating biomarkers for detection of liver cancer with antibody array (36 — 45)

Shuangzhe Zhang, Chunhui Gao, Qi Zhou, Lipai Chen, Gordon Huang, Hao Tang, Xuedong Song, Zhuo Zhang, Kelly Whittaker, Xiaofeng Chen,  Ruo-Pan Huang

DOI: 10.4149/neo_2022_220606N600

Sestrin2 mediates FOXM1 expression to block the EMT process in non-small cell lung cancer through the AMPK/YAP pathway (46 — 57)

Yuan-Li Wang, Qi Wang, Hua Li, Cai-Chun Wang, Yan-Lin Ma,  Zhong Han

DOI: 10.4149/neo_2022_220711N705

Zerumbone combined with gefitinib alleviates lung cancer cell growth through the AKT/STAT3/SLC7A11 axis (58 — 70)

Jin-Guo Wang, Da-Lei Li, Rong Fan,  Meng-Jun Yan

DOI: 10.4149/neo_2022_220418N423

CBX3 promotes breast cancer progression and high level of CBX3 predicts poor prognosis in patients (71 — 81)

Kai Yang, Ya-Lin Wang, Zhen Zhu, Xin-Hui Cao, Ming-Xing Liang, Di Xu, Yin-Jiao Fei, Si-Yuan Yang, Hong-Lei Zhou,  Jin-Hai Tang

DOI: 10.4149/neo_2022_220622N656

HOXA5 inhibits the proliferation and metastasis of cervical squamous cell carcinoma by suppressing the β-catenin/Snail signaling (82 — 93)

Wan-Yu Jin, Yan Zhang, Jia Tian, Long-Kuan Xu, Heng-Jie Lin, Yu-Zhong Yang, Xue-Mei Zhang, Mei-Hua Jin, Wen-Fa Mo, Guang-Ying Qi,  Ying-Qiong Zhou

DOI: 10.4149/neo_2022_220907N908

Triptonide inhibits growth and metastasis in HCC by suppressing EGFR/PI3K/AKT signaling (94 — 102)

Hao Zhang, Yingxuan Mao, Xiaomeng Zou, Jiamei Niu, Jian Jiang, Xi Chen, Mingwei Zhu, Xiuhua Yang,  Tianxiu Dong

DOI: 10.4149/neo_2022_221118N1112

Semaphorin 3A inhibits tumor progression via the downregulation of Lin28B in ovarian cancer (103 — 113)

Ru-Yue Ma, Li-Na Yang, Ji-Na Chen, Ru-Jun Chen,  Li-Wen Zhang,  Xiao-Qin Wang

DOI: 10.4149/neo_2023_220206N139

Cryptotanshinone inhibits oral squamous cell carcinoma through the autophagic pathway (114 — 122)

Xiao-Tian Jiang,  Ye Qiu,  Cong-Hua Li

DOI: 10.4149/neo_2023_220924N957

Cathepsin C promotes colorectal cancer metastasis by regulating immune escape through upregulating CSF1 (123 — 135)

 Yun-Zhi Dang, Xiao-Jiao Chen, Jiao Yu, Shu-Hong Zhao, Xi-Ming Cao, Qing Wang

DOI: 10.4149/neo_2023_220726N757

GOLM1 facilitates human colorectal cancer progression and metastasis via activating the AKT/GSK3β/EMT axis (136 — 144)

Zonglei Mao, Yong Wu, Pingan Yao,  Chungen Xing

DOI: 10.4149/neo_2023_220816N835

Circular RNA hsa_circ_0002938 (circCRIM1) promotes the progression of esophageal squamous cell carcinoma by upregulating transcription factor 12 (145 — 157)

Xiao-Peng Li, Yun-Long Jia, Yu-Qing Duan, Yan Zhao, Xiao-Lei Yin, Shu-Man Zhen, Yi Zhang,  Li-Hua Liu

DOI: 10.4149/neo_2023_220823N857

Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study (158 — 165)

Elvina Almuradova,  Tugba Basoglu, Erdinc Nayir, Ertugrul Bayram, Semra Paydas, Ivo Gokmen, Serdar Karakaya, Berna Oksuzoglu, Dilek Erdem, Abdullah Sakin, Mustafa Atcı, Burcu Belen Gulbagcı, Ilhan Hacibekiroglu, Arif Onder, Serap Karaarslan, Melek Karakurt Eryılmaz, Mustafa Korkmaz, Ozan Yazıcı, Osman Sutcuoglu, Baran Akagunduz, Haci Arak, Teoman Sakalar, Dincer Aydin, Yakup Iriagac, Ozkan Alan, Murat Midik, Denis Cetin, Asli-Dilara Kip, Serdar Turhal, Turgut Kacan, Tolga Koseci

DOI: 10.4149/neo_2022_221004N984

BDNF, sHLA-G, and sTREM-1 are useful blood biomarkers for identifying grade IV glioma patients (166 — 176)

Kristina Kluckova, Jan Kozak, Marian Svajdler, Juraj Steno, Viktor Matejcik, Vladimira Durmanova, Eszter Zsemlye,  Maria Bucova

DOI: 10.4149/neo_2023_221129N1147